{
  "paper_metadata": {
    "pmid": "37706056",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information specifically for the BRCA2 gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8499C>T",
      "protein_notation": "p.S2835*",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 2,
        "demographics": "HR+/HER2\u2212 subgroup",
        "phenotype": "metastatic breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer",
          "evidence_sentence": "In the HR+/HER2\u2212 subgroup one patient was carrier of a gBRCA2 mutation (BRCA2 p.S2835*)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer",
          "evidence_sentence": "In the HR+/HER2\u2212 subgroup two patients were identified with a gBRCA2 mutation (BRCA2 p.S2835*)."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 mutations are associated with increased risk of breast cancer.",
        "assays": []
      },
      "segregation_data": "The gBRCA2 mutations were confirmed by routine genetic analysis due to young age or family history.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No additional functional assays or population frequency data were provided.",
      "key_quotes": [
        "In the HR+/HER2\u2212 subgroup two patients were identified with a gBRCA2 mutation (BRCA2 p.S2835*)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3814C>T",
      "protein_notation": "p.S1271*",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 2,
        "demographics": "HR+/HER2\u2212 subgroup",
        "phenotype": "metastatic breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer",
          "evidence_sentence": "In the HR+/HER2\u2212 subgroup two patients were identified with a gBRCA2 mutation (BRCA2 p.S1271*)."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer",
          "evidence_sentence": "In the HR+/HER2\u2212 subgroup two patients were identified with a gBRCA2 mutation (BRCA2 p.S1271*)."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 mutations are associated with increased risk of breast cancer.",
        "assays": []
      },
      "segregation_data": "The gBRCA2 mutations were confirmed by routine genetic analysis due to young age or family history.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No additional functional assays or population frequency data were provided.",
      "key_quotes": [
        "In the HR+/HER2\u2212 subgroup two patients were identified with a gBRCA2 mutation (BRCA2 p.S1271*)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.9746delA",
      "protein_notation": "p.S3250*",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "HR+/HER2\u2212 subgroup",
        "phenotype": "metastatic breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer",
          "evidence_sentence": "Interestingly the patient with gBRCA1 mutation additionally had a somatic BRCA2 mutation (BRCA2 p.S3250*)."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 mutations are associated with increased risk of breast cancer.",
        "assays": []
      },
      "segregation_data": "The gBRCA2 mutations were confirmed by routine genetic analysis due to young age or family history.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No additional functional assays or population frequency data were provided.",
      "key_quotes": [
        "Interestingly the patient with gBRCA1 mutation additionally had a somatic BRCA2 mutation (BRCA2 p.S3250*)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5627_5628del",
      "protein_notation": "p.E1879fs",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "HER2+ subgroup",
        "phenotype": "metastatic breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer",
          "evidence_sentence": "In Level IIIA we detected one somatic BRCA2 mutation (BRCA2 p.E1879fs) in a HER2+ tumor."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 mutations are associated with increased risk of breast cancer.",
        "assays": []
      },
      "segregation_data": "The gBRCA2 mutations were confirmed by routine genetic analysis due to young age or family history.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No additional functional assays or population frequency data were provided.",
      "key_quotes": [
        "In Level IIIA we detected one somatic BRCA2 mutation (BRCA2 p.E1879fs) in a HER2+ tumor."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 4,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}